QIANG YANG

QIANG YANG is an accomplished scientific leader specializing in chemoenzymatic glycoengineering, antibody-drug conjugates, and protein engineering, with 20 years of experience in therapeutic development and gene therapy. They currently serve as the Director of Protein Engineering at OncoC4, Inc. and previously held significant roles at GlycoT Therapeutics and Cellomics Technology, LLC. Qiang is noted for their leadership in securing multiple SBIR grants totaling $6 million and for their successful technology licensing with major pharmaceutical companies. They earned a PhD in Molecular Biochemistry from the Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences.